Member Exclusive

Company receives funding for next-generation drug discovery platform that uses artificial intelligence technology

Investment will enable company to scale-up its platform to screen more targets and diseases than they were previously capable of

Go to the profile of Hannah Coaker
Oct 06, 2016
0
0

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.